Advisory Services Network’s Cue Biopharma CUE Stock Holding History

Advisory Services Network’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46	Buy	+7	New	+$65	﹤0.01%	4768
2025 Q4	–	Sell	-7	Closed	-$144	–	2344
2025 Q3	$144	Buy	+7	New	+$164	﹤0.01%	4277
2024 Q1	–	Sell	-7	Closed	-$528	–	1918
2023 Q4	$528	Buy	+7	New	+$500	﹤0.01%	3614
2023 Q2	–	Sell	-7	Closed	-$714	–	1919
2023 Q1	$714	Hold	7	–	–	﹤0.01%	3672
2022 Q4	$570	Buy	+7	New	+$640	﹤0.01%	3719
2020 Q4	–	Sell	-3	Closed	-$2K	–	3373
2020 Q3	$2K	Buy	+3	New	+$1.73K	﹤0.01%	3088

Other funds holding CUE

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

GWMR

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

AWM

Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Advisory Services Network's CUE Position: Q1 2026 in Review

Advisory Services Network opened a new position in Cue Biopharma (CUE) in Q1 2026: 7 shares worth $46. The stake represents ﹤0.01% of the portfolio and ranks #4768 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CUE as recently as Q3 2025.

Advisory Services Network first reported a position in CUE in Q3 2020 and has held it in 6 quarters since. The position peaked at $2K in Q3 2020. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

Advisory Services Network held 7 shares of Cue Biopharma worth $46 as of Q1 2026.
Cue Biopharma was a new Advisory Services Network position in Q1 2026.
Cue Biopharma made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4768 holding.
Advisory Services Network first reported a position in Cue Biopharma in Q3 2020 and has held it in 6 quarters since.
Advisory Services Network's Cue Biopharma position peaked at $2K in Q3 2020.
55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.